INCY vs NSP · P/E 14, rev $5.14B vs P/E 35, rev $3.58B
Incyte Corporation (INCY) versus Insperity Inc (NSP) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Insperity Inc (NSP) is a staffing & employment services company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported NSP revenue for 2026-06-30 was $3.58B. Net income was $37.0M. Revenue was up 89.0% from 2026-03-31 to 2026-06-30. NSP currently screens at market cap $2.20B and trailing P/E 34.6.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. NSP currently screens at market cap $2.20B and trailing P/E 34.6.
Not investment advice. Open the INCY and NSP stock pages for the full models.
Not investment advice.